---
annotations:
- id: PW:0000507
  parent: regulatory pathway
  type: Pathway Ontology
  value: estrogen signaling pathway
authors:
- ReactomeTeam
- DeSl
description: In addition to its well-characterized role in estrogen-dependent transcription,
  estrogen (beta-estradiol, also known as E2) also plays a rapid, non-genomic role
  through interaction with receptors localized at the plasma membrane by virtue of
  dynamic palmitoylation. Estrogen receptor palmitoylation is a prerequisite for the
  E2-dependent activation of extra-nuclear signaling both in vitro and in animal models
  (Acconcia et al, 2004; Acconcia et al, 2005; Marino et al, 2006; Marino and Ascenzi,
  2006). Non-genomic signaling through the estrogen receptor ESR1 also depends on
  receptor arginine methylation by PMRT1 (Pedram et al, 2007; Pedram et al, 2012;
  Le Romancer et al, 2008; reviewed in Arnal, 2017; Le Romancer et al, 2011 ). <br>E2-evoked
  extra-nuclear signaling is independent of the transcriptional activity of estrogen
  receptors and occurs within seconds to minutes following E2 administration to target
  cells. Extra-nuclear signaling consists of the activation of a plethora of signaling
  pathways including the RAF/MAP kinase cascade and the PI3K/AKT signaling cascade
  and governs processes such as  apoptosis, cellular proliferation and metastasis
  (reviewed in Hammes et al, 2007; Handa et al, 2012; Lange et al, 2007; Losel et
  al, 2003; Arnal et al, 2017; Le Romancer et al, 2011). ESR-mediated signaling also
  cross-talks with receptor tyrosine kinase, NF- kappa beta and GPCR signaling pathways
  by modulating the post-translational modification of enzymes and other proteins
  and regulating second messengers (reviewed in Arnal et al, 2017; Schwartz et al,
  2016; Boonyaratanakornkit, 2011; Biswas et al, 2005). In the nervous system, E2
  affects neural functions such as cognition, behaviour, stress responses and reproduction
  in part by inducing such rapid extra-nuclear responses (Farach-Carson and Davis,
  2003; Losel et al, 2003), while in endothelial cells, non-genomic ESR-dependent
  signaling also regulates vasodilation through the eNOS pathway (reviewed in Levin,
  2011). <br>Extra-nuclear signaling additionally cross-talks with nuclear estrogen
  receptor signaling and is required to control ER protein stability (La Rosa et al,
  2012)<br>Recent data have demonstrated that the membrane ESR1 can interact with
  various endocytic proteins to traffic and signal within the cytoplasm. This receptor
  intracellular trafficking appears to be dependent on the phyical interaction of
  ESR1 with specific trans-membrane receptors such as IGR-1R and beta 1-integrin (Sampayo
  et al, 2018)  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9009391
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4977
- /instance/WP4977
revision: null
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4977.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: In addition to its well-characterized role in estrogen-dependent transcription,
    estrogen (beta-estradiol, also known as E2) also plays a rapid, non-genomic role
    through interaction with receptors localized at the plasma membrane by virtue
    of dynamic palmitoylation. Estrogen receptor palmitoylation is a prerequisite
    for the E2-dependent activation of extra-nuclear signaling both in vitro and in
    animal models (Acconcia et al, 2004; Acconcia et al, 2005; Marino et al, 2006;
    Marino and Ascenzi, 2006). Non-genomic signaling through the estrogen receptor
    ESR1 also depends on receptor arginine methylation by PMRT1 (Pedram et al, 2007;
    Pedram et al, 2012; Le Romancer et al, 2008; reviewed in Arnal, 2017; Le Romancer
    et al, 2011 ). <br>E2-evoked extra-nuclear signaling is independent of the transcriptional
    activity of estrogen receptors and occurs within seconds to minutes following
    E2 administration to target cells. Extra-nuclear signaling consists of the activation
    of a plethora of signaling pathways including the RAF/MAP kinase cascade and the
    PI3K/AKT signaling cascade and governs processes such as  apoptosis, cellular
    proliferation and metastasis (reviewed in Hammes et al, 2007; Handa et al, 2012;
    Lange et al, 2007; Losel et al, 2003; Arnal et al, 2017; Le Romancer et al, 2011).
    ESR-mediated signaling also cross-talks with receptor tyrosine kinase, NF- kappa
    beta and GPCR signaling pathways by modulating the post-translational modification
    of enzymes and other proteins and regulating second messengers (reviewed in Arnal
    et al, 2017; Schwartz et al, 2016; Boonyaratanakornkit, 2011; Biswas et al, 2005).
    In the nervous system, E2 affects neural functions such as cognition, behaviour,
    stress responses and reproduction in part by inducing such rapid extra-nuclear
    responses (Farach-Carson and Davis, 2003; Losel et al, 2003), while in endothelial
    cells, non-genomic ESR-dependent signaling also regulates vasodilation through
    the eNOS pathway (reviewed in Levin, 2011). <br>Extra-nuclear signaling additionally
    cross-talks with nuclear estrogen receptor signaling and is required to control
    ER protein stability (La Rosa et al, 2012)<br>Recent data have demonstrated that
    the membrane ESR1 can interact with various endocytic proteins to traffic and
    signal within the cytoplasm. This receptor intracellular trafficking appears to
    be dependent on the phyical interaction of ESR1 with specific trans-membrane receptors
    such as IGR-1R and beta 1-integrin (Sampayo et al, 2018)  View original pathway
    at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9009391 Reactome].
  keywords:
  - (i):GDP
  - (inactive)
  - '2xPalmC-MyrG-p-S1177-NOS3 '
  - ADMA
  - ADP
  - 'AREG(101-187) '
  - ATP
  - AdoHcy
  - AdoMet
  - BCL2
  - BCL2 gene
  - 'BH4 '
  - 'BTC(32-111) '
  - 'CALM1 '
  - 'CAV1 '
  - 'CAV2 '
  - CAVs
  - CCND1
  - CCND1 gene
  - 'CCND1 gene '
  - CCND1 gene:p-S133
  - CDKN1B
  - CREB1
  - CREB1 dimer
  - 'Ca2+ '
  - CoA-SH
  - 'EGF '
  - EGF-like
  - EGFR:PTK2
  - ELK1
  - 'EPGN(23-154) '
  - 'ER alpha36 '
  - 'ER alpha46 '
  - 'EREG(60-108) '
  - 'ESR1 '
  - 'ESR2 '
  - ESRs:HSBP1 oligomer
  - ESRs:STRN:ESTG
  - ESRs:STRN:ESTG:MyrG-SRC
  - ESRs:STRN:ESTG:MyrG-pY419 SRC:PI3K alpha
  - ESRs:STRN:ESTG:MyrG-pY419-SRC
  - ESTG
  - 'ESTG '
  - ESTG:ESR1:p-3Y-IGF1R:SHC1
  - ESTG:ESRs:STRN:heterotrimeric G(i) protein
  - ESTG:Me-PalmS-ESR
  - ESTG:Me260-ESR1
  - 'FAD '
  - 'FMN '
  - FOS
  - FOS gene
  - 'FOS gene '
  - FOXO3
  - G-protein Gi
  - G-protein alpha
  - G-protein beta-gamma
  - G1/S transition
  - 'GDP '
  - 'GNAI1 '
  - 'GNAI2 '
  - 'GNAI3 '
  - 'GNAT3 '
  - 'GNB1 '
  - 'GNB2 '
  - 'GNB3 '
  - 'GNB4 '
  - 'GNB5 '
  - 'GNG10 '
  - 'GNG11 '
  - 'GNG12 '
  - 'GNG13 '
  - 'GNG2 '
  - 'GNG3 '
  - 'GNG4 '
  - 'GNG5 '
  - 'GNG7 '
  - 'GNG8 '
  - 'GNGT1 '
  - 'GNGT2 '
  - 'GTP '
  - H2O
  - HB-EGF(161-208)
  - HBEGF(20-208)
  - HBEGF(63-148)
  - 'HBEGF(63-148) '
  - HSBP1 oligomer
  - 'HSBP1 oligomer '
  - 'HSP90AA1 '
  - Heterotrimeric
  - 'IGF1R(31-736) '
  - L-Arg
  - L-Cit
  - 'MMP2(110-660) '
  - MMP2,3,7,9
  - 'MMP3(100-477) '
  - 'MMP7(95-267) '
  - 'MMP9(107-707) '
  - 'Me-PalmS-ESR2 '
  - Me-PalmS-ESRs
  - 'Me260-ESR1 '
  - 'Me260-ESR1:STRN:ESTG: MyrG-pY419 SRC:PI3Kalpha:pY-PTK2'
  - Me260-ESR1:STRN:ESTG:MyrG-pY419 SRC:PI3K alpha
  - 'Me260-PalmS-ESR1 '
  - 'Me87-PalmS-ER alpha36 '
  - 'Me87-PalmS-ER alpha46 '
  - Metabolism of nitric
  - Mitotic G1 phase and
  - MyrG-SRC
  - 'MyrG-SRC '
  - 'MyrG-p-Y419-SRC '
  - NADP+
  - NADPH
  - 'NO'
  - O2
  - PALM(-)
  - PALM-CoA
  - 'PDPK1 '
  - PDPK1:PIP3
  - PDPK1:PIP3:PRKCZ
  - PDPK1:PIP3:p-T410-PRKCZ
  - PDPK1:PIP3:pS,
  - 'PI(3,4,5)P3 '
  - PI3K alpha
  - 'PIK3CA '
  - 'PIK3R1 '
  - 'PIK3R2 '
  - 'PIK3R3 '
  - PIP3 activates AKT
  - PRKCZ
  - 'PRKCZ '
  - PRMT1
  - PTK2
  - 'PTK2 '
  - 'PalmS-ER alpha36 '
  - 'PalmS-ER alpha46 '
  - 'PalmS-ESR1 '
  - 'PalmS-ESR2 '
  - PalmS-ESRs
  - PalmS-ESRs:CAVs
  - PalmS-ESRs:STRN:ESTG
  - RAF/MAP kinase
  - RAS:GDP
  - RAS:GTP
  - 'S-Farn-Me KRAS4B '
  - 'S-Farn-Me PalmS NRAS '
  - 'S-Farn-Me-2xPalmS HRAS '
  - 'S-Farn-Me-PalmS KRAS4A '
  - S1P
  - 'S1P '
  - S1P:S1PR3
  - S1PR3
  - 'S1PR3 '
  - SHC1
  - 'SHC1-1 '
  - 'SHC1-2 '
  - 'SHC1-3 '
  - SPG
  - SPHK1
  - SRF
  - 'SRF '
  - STRN
  - 'STRN '
  - Signaling by EGFR
  - 'TGFA(24-98) '
  - UHMK1
  - XPO1
  - 'ZDHHC21 '
  - 'ZDHHC7 '
  - ZDHHC7, ZDHHC21
  - 'Zn2+ '
  - activation and
  - cascade
  - complex
  - dimer
  - dimer:p-Y397 PTK2
  - dimers
  - gene:SRF:p-4S,T336
  - 'heme '
  - homodimer
  - hydrolase
  - ligands:p-6Y
  - ligands:p-6Y EGFR
  - 'oxide: NOS3'
  - p-4S,T336-ELK1
  - 'p-4S,T336-ELK1 '
  - 'p-6Y-EGFR '
  - p-S10 CDKN1B
  - p-S1177-eNOS:CaM:HSP90:p-AKT1:BH4
  - p-S133-CREB1
  - 'p-S133-CREB1 '
  - p-T,Y MAPK dimers
  - p-T,p-S-AKT
  - p-T185,Y187 MAPK1
  - 'p-T185,Y187-MAPK1 '
  - 'p-T202,Y204-MAPK3 '
  - 'p-T305,S472-AKT3 '
  - 'p-T308,S473-AKT1 '
  - 'p-T309,S474-AKT2 '
  - p-T32,S253,S315-FOXO3
  - p-T410 PRKCZ
  - p-T410 PRKCZ:p21
  - 'p-T410-PRKCZ '
  - p-Y1161,1165,1166-IGF1R
  - 'p-Y1161,Y1165,Y1166-IGF1R(741-1367) '
  - p-Y185,Y187 MAPK1
  - 'p-Y397-PTK2 '
  - p21 RAS:GDP
  - 'pS, p-T410-PRKCZ '
  - pY-PTK2
  - 'pY-PTK2 '
  - palmitoyl-(protein)
  - regulation
  - signaling
  - unknown
  license: CC0
  name: Extra-nuclear estrogen signaling
seo: CreativeWork
title: Extra-nuclear estrogen signaling
wpid: WP4977
---